USSTOCK.TODAY
Market Closed
Log in Sign up

UK MHRA Revokes Marketing Authorization for Valneva's IXCHIQ Vaccine

Investing.com +2 ·

VALN
VALN Valneva SE ADR
$5.69 -3.07%
View chart & analysis →
  1. 1Valneva SE ADRs fell 6.5% in Wednesday after-hours trading.
  2. 2The MHRA revoked the marketing authorization for the IXCHIQ chikungunya vaccine following a benefit-risk review.
  3. 3Valneva decided not to appeal the decision, determining the financial and commercial impact to be minimal.

So what's the key point?

The marketing authorization for Valneva's vaccine was revoked in the UK. The company expects this decision to have little impact on its earnings or sales.

Source Investing.com +2 · View original ↗

Related 3-line summaries

QXO falls 6.65% following RBC price target cut Nasdaq +1 · yesterdayResources Connection Inc. reports $8 million loss for fiscal Q1 Associated Press +2 · yesterdayAnthropic pursues IPO, referencing SpaceX stock trends The Motley Fool +2 · yesterday
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news